Measurement of opioid misuse in the general Mexican population: Encodat 2025.

IF 3.9 4区 医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Andrés Sánchez-Pájaro, Alan Reyes-García, Ariadne Rivera-Aguirre, María José Rivero-Treviño, Silvia L Cruz, Miguel Ángel López-Brambila, Daniel Pech-Puebla, Magdalena Cerdá
{"title":"Measurement of opioid misuse in the general Mexican population: Encodat 2025.","authors":"Andrés Sánchez-Pájaro, Alan Reyes-García, Ariadne Rivera-Aguirre, María José Rivero-Treviño, Silvia L Cruz, Miguel Ángel López-Brambila, Daniel Pech-Puebla, Magdalena Cerdá","doi":"10.21149/18189","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To examine the prevalence of categorical self-reported opioid misuse and compare it to a post hoc corrected indicator in the general Mexican population.</p><p><strong>Materials and methods: </strong>We used data from the 2025 Encuesta Nacional de Consumo de Drogas, Alcohol y Tabaco. We constructed indicators from self-reported categorical heroin/fentanyl use, prescription opioids misuse and opioid misuse and post hoc corrected versions based on the review of open-ended follow up questions by two experts. We estimated the prevalence from categorical self-report responses and compared it with the post hoc corrected indicators.</p><p><strong>Results: </strong>The prevalence of self-reported prescription opioid misuse was 1 948.3 per 100 000 people, which decreased to 1 242.4 after correction. Self-reported heroin or fentanyl use was 370.7 per 100 000 people, with a corrected prevalence of 326.2. Self-reported opioid misuse had a prevalence of 2 229.6 per 100 000 people, which decreased to 1 482.3 after correction.</p><p><strong>Conclusion: </strong>Misclassification was more frequent for prescription opioid misuse than for illicit opioid use. Simple categorical questions performed well for measuring illicit opioid use, but they moderately overestimated prescription and overall opioid misuse.</p>","PeriodicalId":47913,"journal":{"name":"Salud Publica De Mexico","volume":"68 4 (jul-ago)","pages":"342-347"},"PeriodicalIF":3.9000,"publicationDate":"2026-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Salud Publica De Mexico","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21149/18189","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To examine the prevalence of categorical self-reported opioid misuse and compare it to a post hoc corrected indicator in the general Mexican population.

Materials and methods: We used data from the 2025 Encuesta Nacional de Consumo de Drogas, Alcohol y Tabaco. We constructed indicators from self-reported categorical heroin/fentanyl use, prescription opioids misuse and opioid misuse and post hoc corrected versions based on the review of open-ended follow up questions by two experts. We estimated the prevalence from categorical self-report responses and compared it with the post hoc corrected indicators.

Results: The prevalence of self-reported prescription opioid misuse was 1 948.3 per 100 000 people, which decreased to 1 242.4 after correction. Self-reported heroin or fentanyl use was 370.7 per 100 000 people, with a corrected prevalence of 326.2. Self-reported opioid misuse had a prevalence of 2 229.6 per 100 000 people, which decreased to 1 482.3 after correction.

Conclusion: Misclassification was more frequent for prescription opioid misuse than for illicit opioid use. Simple categorical questions performed well for measuring illicit opioid use, but they moderately overestimated prescription and overall opioid misuse.

测量阿片类药物滥用在一般墨西哥人口:Encodat 2025。
目的:检查类别自我报告的阿片类药物滥用的流行程度,并将其与一般墨西哥人群中的事后纠正指标进行比较。材料和方法:我们使用的数据来自2025年全国酒、酒和烟草消费报告。我们根据两位专家对开放式随访问题的回顾,从自我报告的分类海洛因/芬太尼使用、处方阿片类药物滥用和阿片类药物滥用以及事后纠正版本构建指标。我们从分类自我报告反应中估计患病率,并将其与事后校正指标进行比较。结果:自我报告的处方阿片类药物滥用发生率为1 948.3 / 10万人,经纠正后降至1 242.4 / 10万人。自我报告的海洛因或芬太尼使用率为每10万人370.7人,校正后的患病率为326.2人。自我报告的阿片类药物滥用发生率为每10万人2 229.6例,纠正后降至1 482.3例。结论:处方阿片类药物误用比非法阿片类药物误用更常见。简单的分类问题在测量非法阿片类药物使用方面表现良好,但它们适度高估了处方和总体阿片类药物滥用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Salud Publica De Mexico
Salud Publica De Mexico PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-
CiteScore
3.30
自引率
21.70%
发文量
94
审稿时长
34 weeks
期刊介绍: Salud Pública de México se crea en 1959 y comienza a publicarse bimestralmente a partir de 1961; en 1988 inicia una nueva época en la que se refuerza su carácter de publicación científica con evaluación por pares. Es una revista publicada por el Instituto Nacional de Salud Pública (INSP), organismo descentralizado de la Secretaría de Salud de México, dedicado a la investigación, docencia y difusión del conocimiento en salud pública. El INSP, de acuerdo con la normatividad internacional, otorga a la revista independencia editorial.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书